Background and purpose The large vessel occlusion (LVO) in middle cerebral artery (MCA) trunk (i.e., M1 segment) caused by intracranial atherosclerotic disease (ICAD) could introduce with different infarct patterns. We aimed to compare the clinical outcomes among these patterns and investigate the associations between the morphological parameters of contralateral MCA (cMCA) M1 segment and infarct patterns. Methods Patients with stroke attributed to M1-ICAD-LVO were enrolled. The infarct patterns were categorized into artery-artery embolism (AAE), large infarct, borderzone infarct (BZI) and perforating artery infarction (PAI). The morphological parameters of cMCA-M1 segment consisted of proximal diameter, distal diameter, arc length and chord length were measured. The tortuosity index of cMCA-M1 segment was calculated by (arc length/chord length-1) x 100%. Results A total of 171 subjects were enrolled. Compared to AAE, the risk of poor outcome significantly increased in BZI (odds ratio [OR]= 5.51, 95% confidence interval [CI] = 1.71-17.78, p = 0.004) and large infarct (OR= 10.92, 95% CI = 2.01-59.27, p = 0.006), and was comparable in PAI. The tortuosity index (OR= 2.85, 95% CI = 1.13-7.18, p = 0.026) and arc length (OR= 2.47, 95% CI = 1.02-5.97, p = 0.045) significantly elevated in BZI and were identical in other three patterns. Subjects other than BZI were categorized into large infarct (n = 32) and non-large-infarct (n = 46) groups, and the proximal diameter (OR= 0.22, 95% CI = 0.07-0.72, p = 0.012) , arc length (OR= 0.88, 95% CI = 0.78-0.98, p = 0.018) and chord length (OR= 0.87, 95% CI = 0.77-0.995, p = 0.042) were all negatively associated with the onset of large infarct. Conclusion For patients with M1-ICAD-LVO, the outcomes of large infarct and BZI were poorer than AAE and PAI. The cMCA-M1 segment with elevated tortuosity and arc length was associated with BZI, whereas a thin and short M1 segment was correlated with large infarct in patients with a cMCA trunk of low tortuosity.

The authors have declared no competing interest.

This work was supported by grants from Zhenjiang Jinshan Talent Training Program (NO. JSYCBS202202).

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The Scientific Research Ethics Committees of Affiliated Hospital of Jiangsu University and Siyang Hospital

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

All data generated or analyzed during this study could be acquired from the corresponding author through e-mail.